Literature DB >> 2064605

Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural 'architecture'.

D J Thornton1, J K Sheehan, H Lindgren, I Carlstedt.   

Abstract

Mucus glycoproteins (mucins) were isolated from sputum of patients with cystic fibrosis (CF) after separation into sol and gel phases. The mucus gel was solubilized with gentle stirring in 6 M-guanidinium chloride supplemented with proteinase inhibitors, and purification of mucins was subsequently achieved by isopycnic density-gradient centrifugation in CsCl/guanidinium chloride. Density-gradient centrifugation also revealed a heterogeneity of the macromolecules, the pattern of which varied between individuals, and mucins from the gel phase was pooled as 'heavy' and 'light' fractions. Gel chromatography on Sepharose CL-2B showed that the heavy fraction contained a larger proportion of smaller species than the 'light' fraction and that the gel phase mucins were much larger than those from the sol. An apparently homogeneous high-Mr mucin population from one individual contained approx. 70% (w/w) carbohydrate, the major sugars being N-acetylglucosamine (17.8%), N-acetylgalactosamine (6.7%), galactose (20.7%), fucose (13.2%) and sialic acid (11.4%). These mucins had an S020.w of 47 S, and an Mr of 15 x 10(6) -20 x 10(6), and rate-zonal centrifugation revealed a polydisperse size distribution [range (5-30) x 10(6)] with a weight-average Mr of 17 x 10(6). The whole mucins were visualized with electron microscopy as linear and apparently flexible threads, disperse in size. Reduction produced subunits which were included on Sepharose CL-2B, and subsequent trypsin digestion yielded high-Mr glycopeptides which were further retarded. The size distributions and fragmentation patterns of mucin from two other CF patients were the same, as studied by gel chromatography, rate-zonal centrifugation and electron microscopy. We conclude that CF mucins are heterogeneous in both size and buoyant density and that the various populations, though differing in buoyant density, share the same architecture and macromolecular properties and are, in this respect, similar to mucins from normal respiratory secretions [Thornton, Davies, Kraayenbrink, Richardson, Sheehan & Carlstedt (1990) Biochem. J. 265, 179-186] and human cervical mucus [Carlstedt & Sheehan (1989) SEB Symp. XLIII 289-316].

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2064605      PMCID: PMC1151057          DOI: 10.1042/bj2760667

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Further evidence for a flexible and highly expanded spheroidal model for mucus glycoproteins in solution.

Authors:  S E Harding; A J Rowe; J M Creeth
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

2.  Sputum sol-phase proteins and elastase activity in patients with cystic fibrosis.

Authors:  A H Jackson; S L Hill; S C Afford; R A Stockley
Journal:  Eur J Respir Dis       Date:  1984-02

3.  Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis.

Authors:  S Suter; U B Schaad; L Roux; U E Nydegger; F A Waldvogel
Journal:  J Infect Dis       Date:  1984-04       Impact factor: 5.226

4.  The macromolecular structure of human cervical-mucus glycoproteins. Studies on fragments obtained after reduction of disulphide bridges and after subsequent trypsin digestion.

Authors:  I Carlstedt; H Lindgren; J K Sheehan
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

5.  Hydrodynamic properties of human cervical-mucus glycoproteins in 6M-guanidinium chloride.

Authors:  J K Sheehan; I Carlstedt
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

6.  Ultrastructural and histochemical observations of respiratory epithelium and gland.

Authors:  S S Spicer; B A Schulte; L W Chakrin
Journal:  Exp Lung Res       Date:  1983-02       Impact factor: 2.459

7.  Isolation, purification, and properties of respiratory mucus glycoproteins.

Authors:  H Woodward; B Horsey; V P Bhavanandan; E A Davidson
Journal:  Biochemistry       Date:  1982-02-16       Impact factor: 3.162

8.  Oligosaccharides on proteoglycans from the swarm rat chondrosarcoma.

Authors:  L S Lohmander; S De Luca; B Nilsson; V C Hascall; C B Caputo; J H Kimura; D Heinegard
Journal:  J Biol Chem       Date:  1980-07-10       Impact factor: 5.157

9.  Isolation and characterization of human cervical-mucus glycoproteins.

Authors:  I Carlstedt; H Lindgren; J K Sheehan; U Ulmsten; L Wingerup
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

10.  Protease production by Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  A T Hastie; S T Hingley; F Kueppers; M L Higgins; C S Tannenbaum; G Weinbaum
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

View more
  18 in total

1.  Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions.

Authors:  J R Davies; N Svitacheva; L Lannefors; R Kornfält; I Carlstedt
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

2.  Physical characterization of a low-charge glycoform of the MUC5B mucin comprising the gel-phase of an asthmatic respiratory mucous plug.

Authors:  J K Sheehan; M Howard; P S Richardson; T Longwill; D J Thornton
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

Review 3.  Cystic fibrosis: an inherited disease affecting mucin-producing organs.

Authors:  Camille Ehre; Caroline Ridley; David J Thornton
Journal:  Int J Biochem Cell Biol       Date:  2014-03-28       Impact factor: 5.085

4.  Biosynthesis of the MUC2 mucin: evidence for a slow assembly of fully glycosylated units.

Authors:  J K Sheehan; D J Thornton; M Howard; I Carlstedt; A P Corfield; C Paraskeva
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

5.  Susceptibility of the cysteine-rich N-terminal and C-terminal ends of rat intestinal mucin muc 2 to proteolytic cleavage.

Authors:  I A Khatri; G G Forstner; J F Forstner
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

6.  Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells.

Authors:  H W Hovenberg; J R Davies; I Carlstedt
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

7.  Respiratory mucins: identification of core proteins and glycoforms.

Authors:  D J Thornton; I Carlstedt; M Howard; P L Devine; M R Price; J K Sheehan
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

8.  MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions.

Authors:  H W Hovenberg; J R Davies; A Herrmann; C J Lindén; I Carlstedt
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

9.  Mucins in airway secretions from healthy and chronic bronchitic subjects.

Authors:  J R Davies; H W Hovenberg; C J Lindén; R Howard; P S Richardson; J K Sheehan; I Carlstedt
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

10.  Different O-glycosylation of respiratory mucin glycopeptides from a patient with cystic fibrosis.

Authors:  K A Thomsson; I Carlstedt; N G Karlsson; H Karlsson; G C Hansson
Journal:  Glycoconj J       Date:  1998-08       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.